NCT05206370Phase 3Completed

A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers

Study sponsor: Achieve Life Sciences

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-03-21Actual
Enrollment · participants792Actual
Source updated2026-01-14Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Proportion of Participants With Smoking Abstinence During the Last 4 Weeks of 6 Weeks Cytisinicline Treatment Versus Placebo Treatment (Wk 3-6) Measure: Proportion of Participants With Smoking Abstinence During the Last 4 Weeks of 12 Weeks Cytisinicline Treatment Versus Placebo Treatment (Wk 9-12). After: Measure: Percentage of Participants With Smoking Abstinence From Weeks 3 to Week 6 Measure: Percentage of Participants With Smoking Abstinence From Weeks 9 to Week 12.

Check registry source